RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The ...

RBC Capital analyst Kenneth Herbert maintained a Buy rating on Transdigm Group (TDG – Research Report) yesterday and set a price target of ...

He’s expected to join Barrenjoey Capital Partners’ corporate finance ... sector were a major theme for the year, with RBC and Morgan Stanley raising $1.3 billion for NextDC and Barrenjoey ...

Markets sold off on Monday as investors digested Donald Trump's tariff announcements on Mexico, Canada, and China.

RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

Markets sold off on Monday as investors digested Donald Trump's tariff announcements on Mexico, Canada and China.

Find insight on BNP Paribas, UBS, Kasikornbank and more in the latest Market Talks covering Financial Services.

PennyMac Mortgage Investment Trust (NYSE: PMT) (the "Company" or "PMT") today announced that it is commencing an underwritten public offering of senior notes due 2030 (the "Notes"). The Notes will be ...

The three most recent ratings, from Morgan Stanley, RBC Capital and JPMorgan, have an average target of $233.33, implying a 3.32% upside for IBM. IBM Price Action: IBM stock closed the trading day ...

Citi (C), JPMorgan Chase (JPM), Goldman Sachs (GS), and Wells Fargo (WFC) report on Wednesday, while Bank of America (BAC) and Morgan Stanley (MS) release results on Thursday. RBC Capital markets ...

Bank stocks have been on a post-election upswing, with the KBW Nasdaq Bank Index ( ^BKX) up 14% since Trump won the ...